Bacterial infection pattern in ventilated burn patients in the southwest of Iran

Document Type : Research Article

Authors

• Niusha Baserisalehi
• Amir Emami
• Neda Pirbonyeh
• Fatemeh Javanmardi

Microbiology Department, Burn & Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

Burn is one of the most traumatic injuries and life-threatening states which is a global public health problem, accounting for an estimated 180 000 deaths annually. In burn trauma patients, intubation and ventilator-associated pneumonia (VAP) is a major threat. Added to other complications this may be responsible for the higher morbimortality of burn patients. In this one-year cross-sectional study (September 2018 to September 2019), a total of 70 patients hospitalized in the burn ICU ward were sampled according to the study criteria. Cases were hospitalized in Amir-al-Momenin burn hospital, affiliated with Shiraz University of Medical Sciences. Tracheal samples were evaluated for bacterial infection with standard microbiological techniques. In the following process, an antibacterial susceptibility test was performed for confirmed isolates with the Kirby-Bauer method and recommended antibiotics by the Clinical and Laboratory Standards Institute. According to the results of the study, a total of 21 (30%) positive growth samples were detected. The age range of patients was estimated at 1–60 years old with the mean age 29.61±21.56 years. The lowest resistance rate was seen in Pseudomonas aeruginosa and Staphylococcus aureus isolates against gentamycin. Based on the results, it was seen that all Escherichia coli isolates were resistant against all of the examined antibiotics. Appropriate infection control policies and knowing the antimicrobial pattern in burn patients especially in intensive care units may help to provide the best treatment for burn patients and save their life.

Keywords

• Burn
• VAP
• Antibacterial
• Burn ICU
• bacteria

---

References

(CLSI), C.a.L.S.I. (2018). Development of in 
vitro susceptibility testing criteria and 
quality control parameters, Clinical and 
Laboratory Standards Institute (CLSI). 
Albrecht, M.A., Griffith, M.E., Murray, C.K., et 
al. (2006). "Impact of Acinetobacter 
infection on the mortality of burn 
patients." Journal of the American 
College of Surgeons. 203(4): 546-550. 
Ansermino, M. and Hemsley, C. (2004). 
"Intensive care management and control 
of infection." BMJ (Clinical research 
ed.) 329(7459): 220-223. 
Chastre, J., Wolff, M., Fagon, Y., et al. (2003). 
"Comparison of 8 vs 15 days of 
antibiotic therapy for ventilatorassociated pneumonia in adults: a 
randomized trial." Jama. 290(19): 2588-
2598. 
Dennesen, P.J., van der VEN, A.J., Kessels, 
A.G., et al. (2001). "Resolution of 
infectious parameters after antimicrobial 
therapy in patients with ventilatorassociated pneumonia." American 
journal of respiratory and critical care 
medicine. 163(6): 1371-1375. 
Dolp, R., Rehou, S., McCann, M.R., et al. 
(2018). "Contributors to the length-ofstay trajectory in burn-injured patients." 
Burns : journal of the International 
Society for Burn Injuries. 44(8): 2011-
2017. 
Emami, A., Pirbonyeh, N., Keshavarzi, A., et al. 
(2020). "Three Year Study of Infection 
Profile and Antimicrobial Resistance 
Pattern from Burn Patients in Southwest 
Iran." Infection and drug resistance. 13: 
1499. 
Emami, A., Pirbonyeh, N., Moattari, A., et al. 
(2019). "Risk of otitis media with 
effusion (OME) in children by 
Pseudomonas aeruginosa." International 
journal of pediatric otorhinolaryn 
gology. 125: 6-10. 
Huzar, T.F. and M. Cross, J. (2011). "Ventilatorassociated pneumonia in burn patients: a 
cause or consequence of critical 
illness?" Expert Rev Respir Med. 5(5): 
663-673. 
Javanmardi, F., Emami, A., Pirbonyeh, N., et al. 
(2019). "Study of multidrug resistance 
in prevalent Gram-negative bacteria in 
burn patients in Iran: A systematic 
review and meta-analysis." J Glob 
Antimicrob Resist. 19: 64-72. 
Jeong, E.S., Lee, K.S., Heo, S.H., et al. (2013). 
"Rapid identification of Klebsiella 
pneumoniae, Corynebacterium 
kutscheri, and Streptococcus 
pneumoniae using triplex polymerase 
chain reaction in rodents." Exp Anim. 
62(1): 35-40. 
Karimi, H., Momeni, M., Motevalian, A., et al. 
(2014). "The burn registry program in 
1415 N. Baserisalehi et al.,/International Journal of Molecular and Clinical Microbiology 11(1) (2021) 1410-1415 
Iran - First report." Annals of burns and 
fire disasters. 27(3): 154-159. 
Koenig, S.M. and Truwit, J.D. (2006). 
"Ventilator-Associated Pneumonia: 
Diagnosis, Treatment, and Prevention." 
Clin Microbiol Rev. 19(4): 637-657. 
Kollef, M.H. (2003). "The importance of 
appropriate initial antibiotic therapy for 
hospital-acquired infections." The 
American journal of medicine. 115(7): 
582-584. 
Mosier, M.J. and Pham, T.N. (2009). "American 
Burn Association Practice guidelines for 
prevention, diagnosis, and treatment of 
ventilator-associated pneumonia (VAP) 
in burn patients." Journal of Burn Care 
& Research. 30(6): 910-928. 
Roquilly, A., Feuillet, F., Seguin, P., et al. 
(2016). "Empiric antimicrobial therapy 
for ventilator-associated pneumonia 
after brain injury." European 
Respiratory Journal. 47(4): 1219-1228. 
Rutkowska, K., Przybyła, M. and Misiołek, H., 
(2013). "Health-care associated 
infection in the newly-opened intensive 
care unit." Anaesthesiol Intensive Ther. 
45(2): 62-66. 
Santucci, S., Gobara, S., Santos, C., et al. 
(2003). "Infections in a burn intensive 
care unit: experience of seven years." 
Journal of Hospital Infection. 53(1): 6-
13. 
Sen, S., Johnston, C., Greenhalgh, D., et al. 
(2016). "Ventilator-associated 
pneumonia prevention bundle 
significantly reduces the risk of 
ventilator-associated pneumonia in 
critically ill burn patients." Journal of 
Burn Care & Research. 37(3): 166-171. 
Sepsis, A.B.A.C.C.o.B., Group, I., Greenhalgh, 
D.J., et al. (2007). "American Burn 
Association consensus conference to 
define sepsis and infection in burns." 
Journal of burn care & research. 28(6): 
776-790. 
Wahl, W.L., Taddonio, M.A., Arbabi, S., et al. 
(2009). "Duration of antibiotic therapy 
for ventilator-associated pneumonia in 
burn patients." Journal of burn care & 
research. 30(5): 801-806. 
WHO (2018 March). " Burn fact sheet " No. 
365.